Pneumococcal Vaccine articles & resources on Made-in-China.com

Young Children Under 2 Get 2 Shots at Once Are at Increased Risk for Temporary Fever

Jan 8, 2014

Young children who receive flu and pneumococcal vaccines at the same time are at increased risk for temporary fever, a new study reports. While parents should be told about this risk, the benefits of the vaccines outweigh the risks of ...

Tags: children health, pneumococcal vaccines, flu vaccines, temporary fever

CDC Was Published Online on Jan. 6, 2014, in JAMA Pediatrics

Jan 8, 2014

Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study led by researchers from Columbia University Medical Center (CUMC) and the Centers for Disease Control and ...

Tags: Influenza, Pneumococcal Vaccines, Fever, Fever in Children

GSK Has Received Positive Opinion From The EMA's

Oct 30, 2013

British drug maker GlaxoSmithKline (GSK) has received positive opinion from the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) for additional indication for Synflorix, a pediatric pneumococcal ...

Tags: drug, Pneumonia Indication

Pfizer Has Obtained European Approval for The Expanded Use of Prevenar 13

Jul 12, 2013

Pfizer has obtained European approval for the expanded use of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), in adults between 18 to 49 years of age for the prevention of invasive pneumococcal disease. ...

Tags: Pneumococcal Vaccine, Medicine

Liquid Collaborated with PATH to Develop Next Generation Pneumococcal Vaccine

May 27, 2013

Liquidia, the designer and manufacturer of engineered particles, has announced that its collaboration with PATH has been extended to develop next generation Pneumococcal vaccine. The vaccine, if successful, could potentially allow for ...

Tags: Liquidia, Pneumococcal Vaccine

Immunobiology Has Bagged £0.2m in Funding From The UK BBC

Mar 15, 2013

Immunobiology (ImmBio), a UK-based biopharmaceutical company, has bagged £0.2m in funding from the UK government-backed Biomedical Catalyst (BBC) for the pre-clinical development of pneumococcal vaccine PnuBioVax. The pharma company ...

Tags: ImmBio, Biomedical Catalyst, pneumococcal vaccine